Add to ORKGAdding lisinopril to losartan increased hyperkalemia and acute kidney injury in type 2 diabetes and proteinuri
Background Renal disease in people with insulin-dependent diabetes (IDDM) continues to pose a major ...
To assess the effect of an angiotensin receptor blocker (ARB) on serum potassium and the effect of a...
Combining lisinopril and L-arginine slows disease progression and reduces endothelin-1 in passive He...
The pathogenesis of diabetic nephropathy is multifactorial, and the renin−angiotensin−aldosterone sy...
Effect of enalapril and losartan on proteinuria in type 2 diabetic nephropathy patient
Linagliptin is a dipeptidyl peptidase-IV (DPP-IV) inhibitor that is approved for the treatment of ty...
Background Diabetic nephropathy is the leading cause of end-stage renal disease. Interruption of the...
Background: Diabetic nephropathy is the leading cause of end-stage renal disease. Interruption of th...
PubMed: 21479940Hypertension and related oxidative stress are involved in the pathogenesis of any re...
trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, ...
The incidence of hypertension is increased in individuals with diabetes mellitus. This is especially...
Background: Angiotensin-converting enzyme inhibitors have shown antiproteinuric effects in normotens...
Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are well-established glucose-lowering drugs ...
Background and objectivesAngiotensin-converting enzyme inhibitors and angiotensin receptor blockers ...
The antihypertensive and renal effects of the angiotensin-converting enzyme inhibitor lisinopril wer...
Background Renal disease in people with insulin-dependent diabetes (IDDM) continues to pose a major ...
To assess the effect of an angiotensin receptor blocker (ARB) on serum potassium and the effect of a...
Combining lisinopril and L-arginine slows disease progression and reduces endothelin-1 in passive He...
The pathogenesis of diabetic nephropathy is multifactorial, and the renin−angiotensin−aldosterone sy...
Effect of enalapril and losartan on proteinuria in type 2 diabetic nephropathy patient
Linagliptin is a dipeptidyl peptidase-IV (DPP-IV) inhibitor that is approved for the treatment of ty...
Background Diabetic nephropathy is the leading cause of end-stage renal disease. Interruption of the...
Background: Diabetic nephropathy is the leading cause of end-stage renal disease. Interruption of th...
PubMed: 21479940Hypertension and related oxidative stress are involved in the pathogenesis of any re...
trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, ...
The incidence of hypertension is increased in individuals with diabetes mellitus. This is especially...
Background: Angiotensin-converting enzyme inhibitors have shown antiproteinuric effects in normotens...
Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are well-established glucose-lowering drugs ...
Background and objectivesAngiotensin-converting enzyme inhibitors and angiotensin receptor blockers ...
The antihypertensive and renal effects of the angiotensin-converting enzyme inhibitor lisinopril wer...
Background Renal disease in people with insulin-dependent diabetes (IDDM) continues to pose a major ...
To assess the effect of an angiotensin receptor blocker (ARB) on serum potassium and the effect of a...
Combining lisinopril and L-arginine slows disease progression and reduces endothelin-1 in passive He...